torcetrapib has been researched along with d-alpha tocopherol in 1 studies
Studies (torcetrapib) | Trials (torcetrapib) | Recent Studies (post-2010) (torcetrapib) | Studies (d-alpha tocopherol) | Trials (d-alpha tocopherol) | Recent Studies (post-2010) (d-alpha tocopherol) |
---|---|---|---|---|---|
273 | 28 | 83 | 32,198 | 2,903 | 7,258 |
Protein | Taxonomy | torcetrapib (IC50) | d-alpha tocopherol (IC50) |
---|---|---|---|
Glutathione S-transferase P | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Masterjohn, C | 1 |
1 other study(ies) available for torcetrapib and d-alpha tocopherol
Article | Year |
---|---|
Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied.
Topics: Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Endothelium, Vascular; Humans; Hypercholesterolemia; Oxazolidinones; Quinolines; Treatment Outcome; Triglycerides; Vitamin E | 2009 |